Shi-Lu Cao
Overview
Explore the profile of Shi-Lu Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
E J, Liu S, Ma D, Zhang G, Cao S, Li B, et al.
BMC Med Genomics
. 2024 Oct;
17(1):246.
PMID: 39379958
Background: Diabetic nephropathy (DN) has been a major factor in the outbreak of end-stage renal disease for decades. As the underlying mechanisms of DN development remains unclear, there is no...
2.
Cao S, Zhang G, Li J, Bao L, Lan X, Jin Q, et al.
Biomark Med
. 2024 Jan;
17(20):841-848.
PMID: 38180339
To evaluate whether platelet-to-albumin ratio (PAR) can predict diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). A total of 140 patients with T2DM and 40 healthy individuals were enrolled...
3.
Bao L, Lan X, Zhang G, Bao X, Li B, Ma D, et al.
Transl Neurosci
. 2023 Oct;
14(1):20220318.
PMID: 37901140
Objectives: Cyclin-dependent kinase 5 (Cdk5) activity is specifically active in neurogenesis, and Cdk5 and neocortical neurons migration related biomarker are expressed in Cos-7 cells. However, the function of Cdk5 on...
4.
Cao S, Luo H, Gao Y, Lan X, Liu S, Li B, et al.
Front Cell Dev Biol
. 2022 Jul;
10:829067.
PMID: 35874807
Diabetic nephropathy (DN) is one of the leading causes of chronic kidney disease (CKD), during which hyperglycemia is composed of the major force for the deterioration to end-stage renal disease...